Aytu Biopharma Inc (AYTU)

$1.72 -0.04 (-2.00%)
Market Cap 10.76M
Revenue (ttm) 81.00M
Net Income (ttm) -15.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.56%
Debt to Equity Ratio 0.56
Volume 28,700
Avg Vol 39,760
Day's Range N/A - N/A
Shares Out 6.15M
Stochastic %K 36%
Beta -1.43
Analysts Strong Sell
Price Target $8.00

Latest News on AYTU

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 6, 2025, 9:00 AM EST - 12 days ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Aytu BioPharma Disclosure Notification

Dec 3, 2024, 11:45 PM EST - 6 weeks ago

Aytu BioPharma Disclosure Notification

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Nov 22, 2024, 9:00 AM EST - 2 months ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Nov 13, 2024, 7:25 PM EST - 2 months ago

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Nov 13, 2024, 4:05 PM EST - 2 months ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Nov 6, 2024, 5:20 PM EST - 2 months ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 3 months ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Oct 1, 2024, 8:00 AM EDT - 3 months ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Sep 26, 2024, 6:51 PM EDT - 4 months ago

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Sep 26, 2024, 4:15 PM EDT - 4 months ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Sep 19, 2024, 5:30 PM EDT - 4 months ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aug 8, 2024, 5:20 PM EDT - 5 months ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Aug 6, 2024, 8:00 AM EDT - 5 months ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Jun 18, 2024, 8:00 AM EDT - 7 months ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

May 15, 2024, 8:28 PM EDT - 8 months ago

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 15, 2024, 4:05 PM EDT - 8 months ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

May 8, 2024, 4:15 PM EDT - 9 months ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024, 9:00 AM EDT - 10 months ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Feb 14, 2024, 10:52 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 14, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Feb 7, 2024, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Jan 23, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 30, 2023, 8:00 AM EST - 1 year ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Nov 14, 2023, 7:30 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Nov 8, 2023, 8:30 AM EST - 1 year ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Nov 7, 2023, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Oct 26, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Oct 9, 2023, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Sep 27, 2023, 7:01 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Sep 27, 2023, 4:20 PM EDT - 1 year ago

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Sep 21, 2023, 8:25 PM EDT - 1 year ago

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Sep 13, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority

Jul 31, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority

Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Jul 10, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Aytu to Participate in the Maxim Group Virtual Healthcare Conference

Jun 14, 2023, 8:00 AM EDT - 1 year ago

Aytu to Participate in the Maxim Group Virtual Healthcare Conference

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market

Jun 13, 2023, 1:45 PM EDT - 1 year ago

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

Jun 9, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript

May 11, 2023, 9:57 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript

Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results

May 11, 2023, 4:05 PM EDT - 1 year ago

Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results

Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023

May 4, 2023, 4:30 PM EDT - 1 year ago

Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023

Aytu BioPharma Subleases a Portion of Its Manufacturing Facility

May 1, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Subleases a Portion of Its Manufacturing Facility

Aytu BioPharma Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer

Apr 27, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer

Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript

Feb 21, 2023, 9:35 PM EST - 2 years ago

Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript

Aytu BioPharma Reports Second Quarter of Fiscal Year 2023

Feb 21, 2023, 4:10 PM EST - 2 years ago

Aytu BioPharma Reports Second Quarter of Fiscal Year 2023

Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023

Feb 21, 2023, 3:00 PM EST - 2 years ago

Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023

Aytu BioPharma Announces Delayed Filing of Second Quarter Fiscal 2023 Financial Results

Feb 14, 2023, 8:00 AM EST - 2 years ago

Aytu BioPharma Announces Delayed Filing of Second Quarter Fiscal 2023 Financial Results

Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023

Feb 7, 2023, 8:00 AM EST - 2 years ago

Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023

Aytu BioPharma Regains Nasdaq Minimum Bid Price Compliance

Jan 25, 2023, 8:00 AM EST - 2 years ago

Aytu BioPharma Regains Nasdaq Minimum Bid Price Compliance

Aytu BioPharma to Present at Lytham Partners Investor Select Conference on January 31

Jan 24, 2023, 8:00 AM EST - 2 years ago

Aytu BioPharma to Present at Lytham Partners Investor Select Conference on January 31